BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17599376)

  • 1. Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells.
    Moon Y; Yang H; Kim YB
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):155-63. PubMed ID: 17599376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of early growth response gene 1 and interleukin-8 expression by ribotoxin deoxynivalenol (vomitoxin) via ERK1/2 in human epithelial intestine 407 cells.
    Moon Y; Yang H; Lee SH
    Biochem Biophys Res Commun; 2007 Oct; 362(2):256-62. PubMed ID: 17707346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene.
    Bottone FG; Moon Y; Alston-Mills B; Eling TE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):668-77. PubMed ID: 16079301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/PTGF-beta).
    Yang H; Park SH; Choi HJ; Moon Y
    Carcinogenesis; 2010 Apr; 31(4):703-11. PubMed ID: 20130018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
    Moon Y; Bottone FG; McEntee MF; Eling TE
    Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKCĪ“-dependent activation of ERK1/2 leads to upregulation of the human NHE2 transcriptional activity in intestinal epithelial cell line C2BBe1.
    Muthusamy S; Shukla S; Amin MR; Cheng M; Orenuga T; Dudeja PK; Malakooti J
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G317-25. PubMed ID: 22052014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin stimulates expression of early growth response gene-1 and EGF receptor through MAP kinase activation in human colonic epithelial cells.
    Zhao D; Zhan Y; Zeng H; Koon HW; Moyer MP; Pothoulakis C
    Int J Cancer; 2007 Apr; 120(8):1652-6. PubMed ID: 17230532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
    Kambe A; Yoshioka H; Kamitani H; Watanabe T; Baek SJ; Eling TE
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1088-99. PubMed ID: 19934343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells.
    Moon Y; Lee M; Yang H
    Biochem Pharmacol; 2007 Jan; 73(1):125-35. PubMed ID: 17014826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Egr-1 mRNA induction by medium flow involves mRNA stabilization and is enhanced by the p38 inhibitor SB203580 in osteoblast-like cells.
    Ogata T
    Acta Physiol (Oxf); 2008 Nov; 194(3):177-88. PubMed ID: 18485123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of EGR1 and KLF4 by polysulfide via activation of the ERK1/2 and ERK5 pathways in cultured intestinal epithelial cells.
    Arakaki K; Uehara A; Higa-Nakamine S; Kakinohana M; Yamamoto H
    Biomed Res; 2020; 41(3):119-129. PubMed ID: 32522929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of MAPK/ERK1/2 signaling pathway in aldosterone stimulated transforming growth factor-beta1 synthesis in renal tubular epithelial cells].
    Luo Y; Rui HL; Chen YP
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3133-7. PubMed ID: 17313766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth compensatory role of sulindac sulfide-induced thrombospondin-1 linked with ERK1/2 and RhoA GTPase signaling pathways.
    Moon Y; Kim JI; Yang H; Eling TE
    Life Sci; 2008 Mar; 82(11-12):591-9. PubMed ID: 18261746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The translation inhibitor anisomycin induces Elk-1-mediated transcriptional activation of egr-1 through multiple mitogen-activated protein kinase pathways.
    Shin SY; Lee JH; Min B; Lee YH
    Exp Mol Med; 2006 Dec; 38(6):677-85. PubMed ID: 17202844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoke extract induces placental growth factor release from human bronchial epithelial cells via ROS/MAPK (ERK-1/2)/Egr-1 axis.
    Wu D; Yuan Y; Lin Z; Lai T; Chen M; Li W; Lv Q; Yuan B; Li D; Wu B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3031-3042. PubMed ID: 27980400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
    Sun Y; Sinicrope FA
    Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric.
    Einbond LS; Mighty J; Kashiwazaki R; Figueroa M; Jalees F; Acuna UM; Le Gendre O; Foster DA; Kennelly EJ
    Anticancer Agents Med Chem; 2013 Dec; 13(10):1540-50. PubMed ID: 23848206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.